Lebrikizumab After Multiple Prior Advanced Therapies in Moderate‐To‐Severe Atopic Dermatitis: A Real‐World Case Series
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Carmen Cantisani (ORCID: https://orcid.org/0000-0003-2181-951X)
- Giovanni Paolino (ORCID: https://orcid.org/0000-0002-3032-2217)
- Marco Valenti (ORCID: https://orcid.org/0000-0001-9043-3456)
- Matteo Riccardo Di Nicola (ORCID: https://orcid.org/0000-0001-7199-0804)
- Santo Raffaele Mercuri (ORCID: https://orcid.org/0000-0002-9175-4574)
- Luciano Ibba (ORCID: https://orcid.org/0000-0002-7876-4866)
- Alessandra Narcisi (ORCID: https://orcid.org/0000-0002-1938-8581)
- Antonio Costanzo
Institutions
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- IRCCS Humanitas Research Hospital (IT)
- Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-03-22
- DOI
- https://doi.org/10.1111/ijd.70389
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00